Primary care physician Lucy McBride emphasises that GLP-1 drugs are most effective when integrated into comprehensive treatment plans, extending their promise beyond weight loss to potentially reduce alcohol cravings and support behavioural change.
GLP-1 medicines are best understood as part of a wider treatment plan, not a substitute for one. In a Healio column, primary care physician Lucy McBride argued that these drugs can be powerful tools for patients with obesity, diabetes and related metabolic problems, but only when they are paired with protein-focused nutrition, resistance exercise and regular medical follow-up.
McBride described GLP-1s as “sophisticated mind/body drugs” that do more than reduce appetite. She said many patients report a quieter internal dialogue about food, often referred to as “food noise”, alongside meaningful weight loss. For some people, that change can be life-changing, especially after years of repeated advice to “diet and exercise” without success. But she also stressed that not every patient with weight concerns needs medication; some need more structured eating, psychological support or simply more time to prepare healthier meals.
The clinical case for GLP-1 treatment is strongest in obesity, type 2 diabetes and prediabetes. Yale Medicine says the class is used to manage blood sugar and support weight loss, while also lowering the risk of heart and kidney complications in some patients. Drugs.com notes that these medicines work by increasing insulin release when blood sugar rises, suppressing glucagon and slowing digestion, which helps people feel fuller for longer. MedlinePlus adds that they were first developed for diabetes and that their benefits are greatest when combined with diet and exercise.
McBride also pointed to a newer and more tentative area of interest: alcohol cravings. She said some patients taking GLP-1s report less interest in drinking, and she has begun using the drugs off-label for alcohol dependence in carefully selected cases alongside therapy, support groups and monitoring. Still, she warned that addiction is shaped by biological, psychological and social factors, so no single medicine is likely to solve it on its own. For McBride, the promise of GLP-1s lies in what they make possible: not a cure, but a chance to build healthier habits when the appetite quietens.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
